NPI: 1932468923 · WASHINGTON, DC 20018 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 05/10/2012
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP, LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 05/10/2012 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 22,016 | $357K |
| 2019 | 19,520 | $345K |
| 2020 | 14,587 | $336K |
| 2021 | 13,318 | $279K |
| 2022 | 12,580 | $258K |
| 2023 | 6,700 | $177K |
| 2024 | 3,020 | $190K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 31,935 | 2,346 | $1.72M |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 26,261 | 1,433 | $184K |
| J1756 | Injection, iron sucrose, 1 mg | 6,991 | 1,403 | $22K |
| J1270 | Injection, doxercalciferol, 1 mcg | 17,311 | 1,370 | $7K |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 424 | 165 | $6K |
| 0012A | 18 | 15 | $329.70 | |
| 83970 | 789 | 657 | $135.06 | |
| 0011A | 15 | 15 | $118.58 | |
| A4657 | Syringe, with or without needle, each | 4,921 | 1,582 | $45.87 |
| 82728 | 420 | 355 | $25.09 | |
| 85041 | 852 | 735 | $11.51 | |
| 85048 | 848 | 733 | $9.69 | |
| 83550 | 431 | 362 | $7.45 | |
| 83540 | 456 | 381 | $5.53 | |
| G0008 | Administration of influenza virus vaccine | 13 | 13 | $4.00 |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 25 | 21 | $0.00 |
| 82108 | 31 | 29 | $0.00 |